Oral diseasesPub Date : 2025-07-20DOI: 10.1111/odi.15305
Juan Zhang, Guohao Xu, Yongmei Li
{"title":"Comment: Association Between Metabolic Syndrome and Salivary MMP-8, Myeloperoxidase in Periodontitis.","authors":"Juan Zhang, Guohao Xu, Yongmei Li","doi":"10.1111/odi.15305","DOIUrl":"https://doi.org/10.1111/odi.15305","url":null,"abstract":"","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Germline Variations in Patients With Oral Squamous Cell Carcinoma-Systematic Review.","authors":"Mateus José Dutra, Lauren Frenzel Schuch, Felippe José Almeida Loureiro, Felipe Martins Silveira, Marcio Ajudarte Lopes, Manoela Domingues Martins, Wilfredo Alejandro González Arriagada, Daniela Adorno Farias, Ricardo Fernández-Ramires, Vivian Petersen Wagner","doi":"10.1111/odi.70040","DOIUrl":"https://doi.org/10.1111/odi.70040","url":null,"abstract":"<p><strong>Objective: </strong>Integrate studies on germline variations (GV) in patients with oral squamous cell carcinoma (OSCC), aiming to assess the highest frequencies of which genes were altered in patients with this diagnosis.</p><p><strong>Methods: </strong>An electronic search was conducted in four databases and in the gray literature, following the PRISMA 2020 recommendations. Case reports, case series, case-control studies, cross-sectional studies, prospective cohort studies, and retrospective cohort studies reporting GV in patients with OSCC were included for data extraction.</p><p><strong>Results: </strong>Twenty articles were included, covering 146 cases of OSCC. Patients had a mean age of 47.5 years; the majority were male, non-drinkers, and non-smokers. For most cases, p16 staining and human papilloma virus (HPV) status were not investigated/reported. A total of 231 different GV genes were identified in the 146 patients, with the most frequently altered being ND5 (6.1%), CYTB (4.8%), COX1 (4.6%), PDE4DIP (4.1%), ND1 (3.9%), ND4 (3.2%), ND2 (2.7%), ATP6 (2.7%), CDKN2A (2.6%), COX2 (2.4%), COX3 (2.2%), and ND3 and ND6, both accounting for 2% each.</p><p><strong>Conclusion: </strong>This review compiles important data on the most frequent GV in patients with OSCC, enabling new understandings of oral carcinogenesis, as well as future directions for prognosis and treatment.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675357","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral diseasesPub Date : 2025-07-20DOI: 10.1111/odi.70036
Jiaxin Luo, Yang Yang, Yuanyang Li, Zhuoya Cui, Dan Zhao
{"title":"Effect of PTEN Overexpression Plus Anti-PD-1 on Immune Escape in Oral Squamous Cell Carcinoma.","authors":"Jiaxin Luo, Yang Yang, Yuanyang Li, Zhuoya Cui, Dan Zhao","doi":"10.1111/odi.70036","DOIUrl":"https://doi.org/10.1111/odi.70036","url":null,"abstract":"<p><strong>Objectives: </strong>Phosphatase and tensin homolog (PTEN) is an essential regulator of tumor proliferation, apoptosis, and migration. However, the mechanisms by which PTEN regulates immune escape and its implications in immune checkpoint inhibitor combination therapy in oral squamous cell carcinoma (OSCC) remain unclear.</p><p><strong>Methods: </strong>We analyzed the expression of PTEN and PD-L1 in OSCC tissues and cell lines, and their associations with clinicopathological characteristics. The role of PTEN in modulating PD-L1 expression and facilitating tumor immune evasion was investigated using western blotting and T-cell cytotoxicity assays. PTEN regulation efficacy, alone or with immune checkpoint inhibitors, was evaluated in humanized xenograft mice.</p><p><strong>Results: </strong>Reduced PTEN and increased PD-L1 were strongly correlated with high clinical stage, positive lymph node metastasis, and lower CD8<sup>+</sup> T-cell infiltration. Patients with lower PTEN, higher PD-L1, higher clinical stage, and positive lymph node metastasis experienced shorter overall survival. PTEN overexpression suppressed PD-L1 levels and promoted cytotoxic T-cell activity in OSCC cells by inhibiting PI3K/AKT signaling in vitro. Upregulating PTEN alone or combined with anti-PD-1 treatment effectively inhibited OSCC tumor progression and promoted CD8<sup>+</sup> T-cell infiltration in tumors in vivo.</p><p><strong>Conclusions: </strong>PTEN upregulation enhances the antitumor immune response of CD8<sup>+</sup> T-cells, suggesting a potential OSCC immunotherapy strategy.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675356","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral diseasesPub Date : 2025-07-17DOI: 10.1111/odi.70034
Moisés Willian Aparecido Gonçalves, Gabriela Fonseca Rocha, Larissa Doalla de Almeida E Silva, João Luiz de Miranda, Jorge Esquiche León, Cássio Roberto Rocha Dos Santos, Ana Terezinha Marques Mesquita
{"title":"Experience in Creating a Teleconsultation Service in Oral Medicine in the Jequitinhonha Valley During the COVID-19 Pandemic.","authors":"Moisés Willian Aparecido Gonçalves, Gabriela Fonseca Rocha, Larissa Doalla de Almeida E Silva, João Luiz de Miranda, Jorge Esquiche León, Cássio Roberto Rocha Dos Santos, Ana Terezinha Marques Mesquita","doi":"10.1111/odi.70034","DOIUrl":"https://doi.org/10.1111/odi.70034","url":null,"abstract":"","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144650044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral diseasesPub Date : 2025-07-14DOI: 10.1111/odi.70030
Omar Ghanaiem, Gavriel Chaushu, Daya Masri
{"title":"Radiographic Analysis of MRONJ in Osteoporotic and Oncologic Patients on Bisphosphonates or Denosumab.","authors":"Omar Ghanaiem, Gavriel Chaushu, Daya Masri","doi":"10.1111/odi.70030","DOIUrl":"https://doi.org/10.1111/odi.70030","url":null,"abstract":"<p><strong>Introduction: </strong>Medication-Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients. The aim of this study is to compare the radiographic characteristics of MRONJ between osteoporotic and oncologic patients and assess the differences based on treatment type, particularly bisphosphonates and denosumab (RANK-L inhibitors).</p><p><strong>Methods: </strong>A retrospective analysis of 152 MRONJ patients (41 osteoporotic, 111 oncologic) from Rabin-Bilinson Medical Center (2014-2024) examined radiographic features-lytic changes, sclerosis, periosteal reactions, sequestration, and periodontal ligament destruction-using panoramic radiography, CBCT, and MDCT.</p><p><strong>Results: </strong>Sclerosis was more frequent in osteoporotic patients compared to oncologic patients (p < 0.05). No statistically significant differences were found in other radiographic features. Bisphosphonate-induced MRONJ was more frequently accompanied by sclerosis compared to denosumab-related cases in osteoporotic patients (p = 0.0318), while no significant differences were found in the oncologic group.</p><p><strong>Conclusions: </strong>Most of the radiographic features of MRONJ were similar in osteoporotic and oncologic patients. However, sclerosis was more common in osteoporotic patients exposed to Bisphosphonates, which may be due to their prolonged exposure to antiresorptive drugs.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144637692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral diseasesPub Date : 2025-07-13DOI: 10.1111/odi.70026
Chiara Cinquini, Rossana Izzetti, Marco Nisi, Francesco Gulia, Berta Garcia Mira, Antonio Barone
{"title":"Limosilactobacillus reuteri Improves Healing Following Fully Impacted Tooth Extractions: Randomized Clinical Trial.","authors":"Chiara Cinquini, Rossana Izzetti, Marco Nisi, Francesco Gulia, Berta Garcia Mira, Antonio Barone","doi":"10.1111/odi.70026","DOIUrl":"https://doi.org/10.1111/odi.70026","url":null,"abstract":"<p><strong>Objectives: </strong>This randomized, double-blind, placebo-controlled clinical trial evaluated the effect of L. reuteri administration on postsurgical wound healing, pain levels, and patient-reported outcomes (PROs) following extraction of fully impacted teeth.</p><p><strong>Methods: </strong>Consecutive patients requiring surgical extractions were included and randomly allocated to either test (probiotic) or control group (placebo). Following oral hygiene procedures, patients began a daily probiotic/placebo intake 7 days before surgery until 14 days after surgery. Follow-up was performed at 3 (T3), 7 (T7), and 14 (T14) days postop. Wound healing, postoperative complications, pain, perceived functional impairment, and Oral Health Impact Profile-14 (OHIP-14) were registered.</p><p><strong>Results: </strong>A total of 128 patients (67 in the test group and 61 in the control group) were analyzed. Wound healing significantly improved in the test group at T3 and T7. Trismus was significantly milder in the test group at T3 and T14. No differences in pain were noted. The test group experienced reduced chewing impairment and difficulty in oral hygiene procedures, exhibited significantly lower scores of OHIP-14 at T14, and required a reduced number of anti-inflammatory medications in the first 7 days.</p><p><strong>Conclusions: </strong>Limosilactobacillus reuteri administration improved wound healing, reduced the severity of trismus, and was associated with improved PROs following impacted tooth extractions.</p><p><strong>Trial registration: </strong>The study protocol was registered in a clinical trials database (Clinicaltrials.gov) with registration number NCT04903925.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Infectious Complications in Patients Receiving Superselective Intra-Arterial Chemoradiotherapy for Oral Squamous Cell Carcinoma.","authors":"Hideaki Kato, Takashi Ohya, Toshiyuki Koizumi, Masaki Iida, Shoko Takano, Masaharu Hata, Hideaki Nakajima, Kenji Mitsudo","doi":"10.1111/odi.70027","DOIUrl":"https://doi.org/10.1111/odi.70027","url":null,"abstract":"<p><strong>Objective: </strong>Superselective intra-arterial chemoradiotherapy (IACRT) is a radical treatment performed to preserve function in patients with oral cancer. However, the characteristics of infectious complications in this patient population and the prognostic impact remain unclear.</p><p><strong>Methods: </strong>We retrospectively reviewed 245 consecutive patients who underwent IACRT from 2008 to 2016. The characteristics of those who developed infectious complications during IACRT were compared with those who did not.</p><p><strong>Results: </strong>One hundred eighty-four infectious complications occurred during IACRT in 133/245 (54%) patients, including intra-arterial catheter site infection (19.0%, 2.7/1000 catheter-days), central line- and peripheral catheter-associated bloodstream infection (8.7%), febrile neutropenia (16.3%), pneumonia (8.7%), Clostridioides difficile infection (8.7%) and fever of unknown origin (26.6%). Multivariate regression analysis revealed that central venous catheter placement (adjusted odds ratio: 1.42) and Grade 3/4 neutropenia (adjusted odds ratio: 1.23) were significantly associated with infectious complications. Patients with infectious complications during IACRT had a worse prognosis than those without, with 5-year overall survival rates of 66.2% and 79.4%, respectively.</p><p><strong>Conclusions: </strong>Infectious complications during IACRT interrupt the course of cancer treatment, worsening prognosis. Thus, close monitoring and infection prevention measures are suggested to improve prognosis in patients with oral cancer undergoing IACRT.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral diseasesPub Date : 2025-07-13DOI: 10.1111/odi.70032
Chen Li, Yi-Hang Li, Yun-Hao Zheng, Wei Li, Po-Kam Wo, Ji Woon Park, Jun Wang, Xin Xiong
{"title":"Reporting Quality of Adverse Events in Temporomandibular Disorders Treatment: A Systematic Review.","authors":"Chen Li, Yi-Hang Li, Yun-Hao Zheng, Wei Li, Po-Kam Wo, Ji Woon Park, Jun Wang, Xin Xiong","doi":"10.1111/odi.70032","DOIUrl":"https://doi.org/10.1111/odi.70032","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the quality of adverse event (AE) reporting and identify factors associated with reporting quality in randomized controlled trials (RCTs) of temporomandibular disorders (TMDs) treatment.</p><p><strong>Methods: </strong>We searched MEDLINE, Cochrane Library (CENTRAL), and EMBASE for RCTs on TMD treatment. Trial characteristics and AE data were extracted, with specific AEs classified using System Organ Class (SOC) terminology. We assessed the reporting quality with the 16-item CONSORT Harms 2022 checklist. Factors influencing reporting quality were analyzed using multiple linear regression and an artificial neural network (ANN) with SHapley Additive exPlanations (SHAP) interpretation.</p><p><strong>Results: </strong>Of 79 RCTs analyzed, neurological symptoms (e.g., headache, dizziness) were the primary AEs. Only three checklist items were reported in over 50% of studies. The median reporting score percentage was 18.8% (IQR 26.7%). No significant differences in score percentages were observed across treatment modalities (p = 0.565). We finally screened out five key factors linked to higher reporting quality, including non-profit funding, combined efficacy-safety endpoints, absence of international collaboration, European country location, and registration status.</p><p><strong>Conclusions: </strong>AE reporting quality in TMDs treatment RCTs remains suboptimal. Adherence to the most current CONSORT Harms guidelines is recommended to improve transparency and consistency in harms reporting.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626891","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Oral diseasesPub Date : 2025-07-08DOI: 10.1111/odi.70019
Li Tang, Yangying Duan, Ke Yang, Dong Wang, Huan Yao
{"title":"LIPUS Protects PDLSCs From Oxidative Damage and Promotes Alveolar Bone Regeneration via FOXO1.","authors":"Li Tang, Yangying Duan, Ke Yang, Dong Wang, Huan Yao","doi":"10.1111/odi.70019","DOIUrl":"https://doi.org/10.1111/odi.70019","url":null,"abstract":"<p><strong>Objective: </strong>Oxidative stress is regarded as a significant element contributing to periodontal tissue destruction and impaired regeneration. Low-intensity pulsed ultrasound (LIPUS) has been shown to effectively protect periodontal ligament stem cells (PDLSCs) from oxidative damage. However, the potential molecular mechanism of LIPUS remains unclear.</p><p><strong>Methods: </strong>The experimental periodontitis model was established by ligation. The expression levels of oxidative stress and osteogenic markers in vivo were detected by immunohistochemistry. PDLSCs were incubated with H<sub>2</sub>O<sub>2</sub> to imitate oxidative stress. A reactive oxygen species assay kit was used to determine oxidative stress status. The expression of osteogenic differentiation protein, Forkhead transcription factor-1 (FOXO1) and antioxidant protein was observed by Western blotting. SiRNA technology and the small molecule inhibitor AS1842856 were used to evaluate the role of FOXO1 in LIPUS treatment.</p><p><strong>Results: </strong>The results demonstrated that LIPUS exerts a protective effect against oxidative damage in PDLSCs, reduces alveolar bone loss, and significantly inhibits the elevated phosphorylation levels of FOXO1 in the oxidative stress microenvironment. Moreover, the increased phosphorylation level of FOXO1 diminishes the protective effect of LIPUS.</p><p><strong>Conclusion: </strong>Thus, these results suggest that FOXO1 may be a critical target for LIPUS to attenuate oxidative stress and regulate alveolar bone homeostasis in periodontitis.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":""},"PeriodicalIF":2.9,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144584467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}